Clinical Trials Browser

Phase 2 × sotigalimab × 90 days × Clear all

NCT04130854 2026-01-28

INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer

Phase 2 Active not recruiting

Gastrointestinal

Locally Advanced Rectal Adenocarcinoma